Related Experiment Video
Updated: Mar 2, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Doxorubicin-induced cardiomyocyte apoptosis: Role of mitofusin 2
Background:
Doxorubicin (DOX) is an anti-tumor agent that is widely used in clinical setting for cancer treatment. The application of the DOX, however, is limited by its cardiac toxicity which can induce heart failure through an undefined mechanism. Mitofusin 2 (Mfn2) is a mitochondrial GTPase fusion protein that is located on the outer membrane of mitochondria (OMM). The Mfn2 plays an important role in mitochondrial fusion and fission. The aim of this study is to identify the role of the Mfn2 in DOX-induced cardiomyocyte apoptosis.
Methods:
Cultured neonatal rat cardiomyocytes were used in this study. Mfn2 expression in cardiomyocytes was determined after the cardiomyocytes were challenged with DOX. Cardiomyocyte mitochondrial fission, mitochondrial reactive oxygen species (ROS) production was assessed with mitochondrial fragmentation and MitoSOX fluorescence probe, respectively. Cardiomyocyte apoptosis was determined with caspase3 activity and TUNEL staining.
Results:
Challenging of the cardiomyocytes with DOX resulted in increasing in cardiomyocyte oxidative stress and apoptosis. In addition, levels of Mfn2 in cardiomyocytes were decreased after the cells were challenged with DOX which was associated with increased mitochondrial fission (fragmentation) and mitochondrial ROS production. An increase in cardiomyocyte levels of Mfn2 attenuated the DOX-induced increase in mitochondrial fission and prevented cardiomyocyte mitochondrial ROS production. An increase in cardiomyocyte levels of Mfn2 or pretreatment of cardiomyocytes with an anti-oxidant, Mito-tempo, also prevented the DOX-induced cardiomyocyte apoptosis.
Conclusion:
Our results indicate that DOX results in a decreased cardiomyocyte Mfn2 expression which promotes mitochondrial fission and ROS production further leads to cardiomyocyte apoptosis.
Insights
Doxorubicin (DOX) treatment decreases Mitofusin 2 (Mfn2) in heart cells, increasing mitochondrial damage and apoptosis. Restoring Mfn2 levels protects against DOX-induced cardiotoxicity.
Area of Science:
- Cardiology
- Molecular Biology
- Toxicology
Background:
- Doxorubicin (DOX) is a vital anti-cancer drug.
- DOX causes cardiotoxicity, leading to heart failure via unknown mechanisms.
- Mitofusin 2 (Mfn2) regulates mitochondrial fusion and is crucial for mitochondrial health.
Purpose of the Study:
- Investigate the role of Mfn2 in Doxorubicin-induced cardiomyocyte apoptosis.
- Determine if Mfn2 levels influence mitochondrial dysfunction during DOX treatment.
Main Methods:
- Neonatal rat cardiomyocytes were exposed to DOX.
- Mfn2 expression, mitochondrial fission, reactive oxygen species (ROS) production, and apoptosis were measured.
- Mfn2 levels were manipulated to assess its protective effects.
Main Results:
- DOX exposure increased cardiomyocyte oxidative stress and apoptosis.
- DOX reduced Mfn2 levels, correlating with increased mitochondrial fission and ROS.
- Elevated Mfn2 attenuated DOX-induced mitochondrial fission and ROS production.
- Increased Mfn2 or antioxidant treatment protected cardiomyocytes from DOX-induced apoptosis.
Conclusions:
- DOX diminishes Mfn2 expression in cardiomyocytes.
- Reduced Mfn2 exacerbates mitochondrial fission and ROS production, causing apoptosis.
- Mfn2 plays a protective role against DOX cardiotoxicity.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
The Extrinsic Apoptotic Pathway
Cardiomyopathy II: Dilated Cardiomyopathy
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...

